Zhishu Biotechnology

About:

Zhishu Biotechnology specialized in the investigation and creation of products for treating injuries to the central nervous system.

Top Investors: Zhongke Advanced Fund, Brain Innovation Center

Description:

Zhishu Biotechnology specialized in the investigation and creation of products for treating injuries to the central nervous system. It fundamentally resolves the issue of central nervous system damage healing and has produced a new model for treating traumatic central nervous system injury by triggering endogenous neurogenesis to produce new neurons.

Total Funding Amount:

30M CNY

Headquarters Location:

Fengtai, Beijing, China

Founded Date:

2021-01-01

Founders:

Number of Employees:

51-100

Last Funding Date:

2023-04-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai